TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 SEK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
787
|
1,264
|
780 |
| Financial expenses |
110
|
444
|
426 |
| Earnings before taxes |
-115
|
98
|
69 |
| EBITDA |
-16
|
542
|
484 |
| Total assets |
14,554
|
15,047
|
15,144 |
| Current assets |
766
|
1,163
|
935 |
| Current liabilities |
256
|
390
|
271 |
| Equity capital |
14,232
|
14,547
|
14,754 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
97.8%
|
96.7%
|
97.4% |
| Turnover per employee |
787
|
1,264
|
780 |
| Profit as a percentage of turnover |
-14.6%
|
7.8%
|
8.8% |
| Return on assets (ROA) |
0.0%
|
3.6%
|
3.3% |
| Current ratio |
299.2%
|
298.2%
|
345.0% |
| Return on equity (ROE) |
-0.8%
|
0.7%
|
0.5% |
| Change turnover |
-477
|
484
|
297 |
| Change turnover % |
-38%
|
62%
|
61% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.